Cargando…

Targeting chaperone-mediated autophagy for Parkinson’s disease therapy

Detalles Bibliográficos
Autores principales:	Wang, Yi-Ting, Lu, Jia-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154472/ https://www.ncbi.nlm.nih.gov/pubmed/36751793 http://dx.doi.org/10.4103/1673-5374.363831

Ejemplares similares

Chaperone-Mediated Autophagy in Neurodegenerative Diseases: Molecular Mechanisms and Pharmacological Opportunities
por: Wang, Yi-Ting, et al.
Publicado: (2022)

Chaperone-Mediated Autophagy and Mitochondrial Homeostasis in Parkinson's Disease
por: Yang, Ruixin, et al.
Publicado: (2016)

Chaperoning glucocerebrosidase: a therapeutic strategy for both Gaucher disease and Parkinsonism
por: McMahon, Benjamin, et al.
Publicado: (2016)

Role of Chaperone-Mediated Autophagy Dysfunctions in the Pathogenesis of Parkinson’s Disease
por: Sala, Gessica, et al.
Publicado: (2016)

Chaperone proteins as ameliorators of α-synuclein-induced synaptic pathologies: insights into Parkinson’s disease
por: Banks, Susan M.L., et al.
Publicado: (2020)

Gene therapy in Parkinson's disease: targeting the endplasmic reticulum proteostasis network
por: Castillo, Valentina, et al.
Publicado: (2015)

The unhappy chaperone
por: Linse, Sara, et al.
Publicado: (2021)

Cell Therapies for Parkinson's Disease
por: Irion, Stefan
Publicado: (2019)

Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease
por: Alvarez-Erviti, L, et al.
Publicado: (2013)

Chemical Chaperone and Inhibitor Discovery: Potential Treatments for Protein Conformational Diseases
por: Zhao, Jian-Hua, et al.
Publicado: (2007)

Response to “Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real‐World Data”
por: Müntze, Jonas, et al.
Publicado: (2019)

Chaperone-mediated autophagy: roles in neurodegeneration
por: Wang, Gang, et al.
Publicado: (2014)

The Complex Role of Chaperone-Mediated Autophagy in Cancer Diseases
por: Liu, Jing, et al.
Publicado: (2023)

The Role of Chaperone-Mediated Autophagy in Huntingtin Degradation
por: Qi, Lin, et al.
Publicado: (2012)

Proteome-wide analysis of chaperone-mediated autophagy targeting motifs
por: Kirchner, Philipp, et al.
Publicado: (2019)

Tetrahydrohyperforin (IDN5706) targets the endoplasmic reticulum for autophagy activation: potential mechanism for Alzheimer's disease therapy
por: González, Alexis, et al.
Publicado: (2016)

Potential role of biofeedback therapy for Parkinson’s disease
por: Kotani, Naoya, et al.
Publicado: (2021)

Rebound excitability mediates motor abnormalities in Parkinson’s disease
por: Kim, Jeongjin, et al.
Publicado: (2018)

Fabry Disease: Switch from Enzyme Replacement Therapy to Oral Chaperone Migalastat: What Do We Know Today?
por: Perretta, Fernando, et al.
Publicado: (2023)

The neuroprotective potential of endoplasmic reticulum chaperones
por: McLaughlin, Todd, et al.
Publicado: (2015)

Autophagy takes it all – autophagy inducers target immune aging
por: Zinecker, Heidi, et al.
Publicado: (2022)

Chaperone-Based Therapies for Disease Modification in Parkinson's Disease
por: Friesen, Erik L., et al.
Publicado: (2017)

Gut microbiota: a potential therapeutic target for Parkinson’s disease
por: Baizabal-Carvallo, José Fidel
Publicado: (2020)

Genetics provides new individualized therapeutic targets for Parkinson’s disease
por: Garcia, Eric Joshua, et al.
Publicado: (2020)

Correction: Proteome-wide analysis of chaperone-mediated autophagy targeting motifs
por: Kirchner, Philipp, et al.
Publicado: (2022)

Chaperone-mediated autophagy substrate proteins in cancer
por: Tang, Ying, et al.
Publicado: (2017)

Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis
por: Qiao, Lei, et al.
Publicado: (2021)

Molecular chaperones and their denaturing effect on client proteins
por: Hiller, Sebastian
Publicado: (2020)

Real world studies are essential for drug therapy in Parkinson’s disease
por: Müller, Thomas
Publicado: (2018)

New perspectives in iron chelation therapy for the treatment of Parkinson’s disease
por: Nuñez, Marco T., et al.
Publicado: (2019)

Chaperone‐mediated autophagy: Molecular mechanisms, biological functions, and diseases
por: Yao, Ruchen, et al.
Publicado: (2023)

Chaperone Mediated Autophagy in the Crosstalk of Neurodegenerative Diseases and Metabolic Disorders
por: Alfaro, Iván E., et al.
Publicado: (2019)

New Insights into the Mechanisms of Chaperon-Mediated Autophagy and Implications for Kidney Diseases
por: Yuan, Zhen, et al.
Publicado: (2022)

Sigma-1 receptor: a potential new target for Parkinson's disease?
por: Francardo, Veronica
Publicado: (2014)

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2017)

Interplay of LRRK2 with chaperone-mediated autophagy
por: Orenstein, Samantha J., et al.
Publicado: (2013)

Humanin is an endogenous activator of chaperone-mediated autophagy
por: Gong, Zhenwei, et al.
Publicado: (2018)

Chaperone-Mediated Autophagy in the Liver: Good or Bad?
por: Dash, Srikanta, et al.
Publicado: (2019)

Chaperone Mediated Autophagy Substrates and Components in Cancer
por: Rios, Javiera, et al.
Publicado: (2021)

Chaperone-mediated autophagy protects against atherosclerosis
por: Madrigal-Matute, Julio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7af7sji6mi4redfekq082da4iq